Intracellular ANKRD1 protein levels are regulated by 26S proteasome-mediated degradation

FEBS Letters

Volumn 583, Issue 15, 2009, Pages 2486-2492

  Badi, Ileana ^a   Cinquetti, Raffaella ^a   Frascoli, Michela ^a   Parolini, Cinzia ^b   Chiesa, Giulia ^b   Taramelli, Roberto ^a   Acquati, Francesco ^a  

^a UNIVERSITY OF INSUBRIA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

26S proteasome; ANKRD1; Cardiac transcriptional regulator; PEST sequence

Indexed keywords

CELL PROTEIN; MUSCLE PROTEIN; PROTEASOME; PROTEIN ANKRD1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN DETERMINATION; PROTEIN FUNCTION; PROTEIN MOTIF; PROTEIN PROTEIN INTERACTION;

AMINO ACID SEQUENCE; GENE EXPRESSION REGULATION, DEVELOPMENTAL; HEART DEFECTS, CONGENITAL; HELA CELLS; HUMANS; MUSCLE PROTEINS; NUCLEAR PROTEINS; PROTEASOME ENDOPEPTIDASE COMPLEX; RECOMBINANT PROTEINS; REPRESSOR PROTEINS;

EID: 67849084810     PISSN: 00145793     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.febslet.2009.07.001     Document Type: Article

References (14)

1. Ehrmann M., and Clausen T. Proteolysis as a regulatory mechanism. Annu. Rev. Genet. 38 (2004) 709-724
2. Varshavsky A. Regulated protein degradation. Trends Biochem. Sci. 30 (2005) 283-286
3. Gloter M., Murray A., and Kirschner M.W. Cyclin is degraded by the ubiquitin pathway. Nature 349 (1991) 132-138
4. Cottrell G.S., Coelho A.M., and Bunnett N.W. Protease-activated receptors: the role of cell-surface proteolysis in signalling. Essays Biochem. 38 (2002) 169-183
5. Desterro J.M.P., Rodriguez M.S., and Hay R.T. Regulation of transcription factors by protein degradation. Cell. Mol. Life Sci. 57 (2000) 1207-1219
6. Suzuki K., Hata S., Kawabata Y., and Sorimachi H. Structure, activation, and biology of calpain. Diabetes 53 Suppl 1 (2004) S12-18
7. Turk V., Turk B., and Turk D. Lysosomal cysteine proteases: facts and opportunities. EMBO J. 20 (2001) 4629-4633
8. Reinstein E., and Ciechanover A. Narrative review: protein degradation and human diseases: the ubiquitin connection. Ann. Intern. Med. 145 (2006) 676-684
9. Muratani M., and Tansey W.P. How the ubiquitin-proteasome system controls transcription. Nat. Rev. Mol. Cell. Biol. 4 (2003) 192-201
10. Correa-Villaseñor A., Ferencz C., Boughman J.A., and Neill C.A. Total anomalous pulmonary venous return: familial and environmental factors. Teratology 44 (1991) 415-428
11. Cinquetti R., et al. Transcriptional deregulation and a missense mutation define ANKRD1 as a candidate gene for total anomalous pulmonary venous return. Hum. Mut. 29 (2008) 468-474
12. Xiu M., et al. The transcriptional repressor HBP1 Is a Target of the p38 mitogen-activated protein kinase pathway in cell cycle regulation. Mol. Cell. Biol. 23 (2003) 8890-8901
13. Chu W., Burns D.K., Swerlick R.A., and Presky D.H. Identification and characterization of a novel cytokine-inducible nuclear protein from human endothelial cells. J. Biol. Chem. 270 (1995) 10236-10245
14. Jeyaseelan R., et al. A novel cardiac-restricted target for doxorubicin. J. Biol. Chem. 272 (1997) 22800-22808